NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. ("Kyverna Therapeutics, Inc." or the "Company") (NASDAQ: KYTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyverna Therapeutics, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all those who purchased or otherwise acquired Kyverna common stock pursuant and/or traceable to the Compan ...

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Grocery Outlet Holding Corp. ("Grocery Outlet" or the "Company") (NASDAQ: GO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Grocery Outlet investors who were adversely affected by alleged securities fraud between November 7, 2023 and May 7, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/grocer ...

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. ("BioAge" or the "Company") (NASDAQ: BIOA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioAge investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all shareholders that purchased stock pursuant and/or traceable to BioAge’s registration statement for the initial public offering held on or about Septemb ...

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Regeneron investors who were adversely affected by alleged securities fraud between November 2, 2023 and October 30, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/regene ...

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Pacira investors who were adversely affected by alleged securities fraud between August 2, 2023 and August 8, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/pacira-biosciences-inc- ...

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Innovative Industrial Properties, Inc. ("Innovative Industrial Properties" or the "Company") (NYSE: IIPR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Innovative Industrial Properties investors who were adversely affected by alleged securities fraud between February 27, 2024 and December 19, 2024. Follow the link below to get more information and be contacted by ...

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cassava Sciences, Inc. ("Cassava Sciences, Inc." or the "Company") (NASDAQ: SAVA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cassava Sciences, Inc. investors who were adversely affected by alleged securities fraud between February 7, 2024 and November 24, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk. ...

Advancements and Projections in the Global Clinical Trial Supply and Logistics Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew York, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Overview: According to Dimension Market Research, the global clinical trial supply and Logistics Market is expected to reach USD 4,000.7 million by 2025 and USD 7,926.1 million by 2034. The market is anticipated to register a CAGR of 7.9% from 2025 to 2034. The global clinical trials logistics and supply base is developing ...

Bioinformatics Market Projected to Experience Significant Growth by 2034 Driven by AI, Precision Medicine, NGS Technologies and Cloud Solutions.New York, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Overview The Bioinformatics Market size is expected to reach USD 13.3 billion by 2025 and is further anticipated to reach USD 44.0 billion by 2034 according to Dimension Market Research. The market is anticipated to register a CAGR of 14.2% from 2025 to 2034. With lots of improvements in genomics, proteomics techniques, an ...

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in ESSA Pharma Inc. ("ESSA Pharma Inc." or the "Company") (NASDAQ: EPIX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ESSA Pharma Inc. investors who were adversely affected by alleged securities fraud between December 12, 2023 and October 31, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/essa-p ...